Tag: Drug
AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
GSK expands deal worth $ 10.6B for lung cancer treatment
GSK plc and Nuvalent, Inc. announced that they have entered into a definitive agreement under which GSK will acquire Nuvalent, a clinical-stage biopharmaceutical company focused on...
Roche Enters BTK Degrader Space with $2.3B Nurix Therapeutics Alliance
Roche and Nurix Therapeutics, Inc. announced a definitive global licensing and collaboration agreement to co-develop and co-commercialize bexobrutideg (NX-5948), an investigational, orally bioavailable Bruton’s Tyrosine Kinase (BTK) degrader. The transaction, valued...
CDSCO Tightens Action Against Banned Antibiotics After Shrimp Export Rejections Jump 43%
The Central Drugs Standard Control Organisation (CDSCO), under India's Ministry of Health and Family Welfare, has issued a directive to all State and Union...
Solaris Pharma Launches Generic Briviact®️ to Improve Access to Epilepsy Treatment
Solaris Pharma has launched brivaracetam tablets — the generic equivalent of UCB's Briviact® — marking a notable pivot for a company long anchored in...
Nepal Seeks IIT and AIIMS Campuses to Adopt India’s Success Path
In a landmark move to redefine bilateral cooperation, Nepal’s Minister for Foreign Affairs, Shisir Khanal, has formally proposed the establishment of Indian Institute of...